These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 30826427)

  • 1. Pyruvate kinase M2: A multifarious enzyme in non-canonical localization to promote cancer progression.
    Amin S; Yang P; Li Z
    Biochim Biophys Acta Rev Cancer; 2019 Apr; 1871(2):331-341. PubMed ID: 30826427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyruvate kinase M2: A simple molecule with complex functions.
    Alquraishi M; Puckett DL; Alani DS; Humidat AS; Frankel VD; Donohoe DR; Whelan J; Bettaieb A
    Free Radic Biol Med; 2019 Nov; 143():176-192. PubMed ID: 31401304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rocking cell metabolism: revised functions of the key glycolytic regulator PKM2 in cancer.
    Chaneton B; Gottlieb E
    Trends Biochem Sci; 2012 Aug; 37(8):309-16. PubMed ID: 22626471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PKM2, a potential target for regulating cancer.
    Li YH; Li XF; Liu JT; Wang H; Fan LL; Li J; Sun GP
    Gene; 2018 Aug; 668():48-53. PubMed ID: 29775756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the diverse role of pyruvate kinase M2 in cancer: Navigating beyond glycolysis and the Warburg effect.
    Upadhyay S; Khan S; Hassan MI
    Biochim Biophys Acta Rev Cancer; 2024 May; 1879(3):189089. PubMed ID: 38458358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Novel mechanism for invasion and metastasis involving metabolic enzymes in intractable cancer cells].
    Konno M; Hamabe A; Doki Y; Mori M; Ishii H
    Rinsho Ketsueki; 2015 Aug; 56(8):1059-63. PubMed ID: 26345567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs oxphos and prostate cancer metastatic spread.
    Giannoni E; Taddei ML; Morandi A; Comito G; Calvani M; Bianchini F; Richichi B; Raugei G; Wong N; Tang D; Chiarugi P
    Oncotarget; 2015 Sep; 6(27):24061-74. PubMed ID: 26183399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of PKM2 in cancer progression and its structural and biological basis.
    Wu B; Liang Z; Lan H; Teng X; Wang C
    J Physiol Biochem; 2024 May; 80(2):261-275. PubMed ID: 38329688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PKM2 Thr454 phosphorylation increases its nuclear translocation and promotes xenograft tumor growth in A549 human lung cancer cells.
    Yu Z; Huang L; Qiao P; Jiang A; Wang L; Yang T; Tang S; Zhang W; Ren C
    Biochem Biophys Res Commun; 2016 May; 473(4):953-958. PubMed ID: 27045080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of PKM2 in Metabolic Reprogramming: Insights into the Regulatory Roles of Non-Coding RNAs.
    Puckett DL; Alquraishi M; Chowanadisai W; Bettaieb A
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33503959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PKM2, cancer metabolism, and the road ahead.
    Dayton TL; Jacks T; Vander Heiden MG
    EMBO Rep; 2016 Dec; 17(12):1721-1730. PubMed ID: 27856534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The multifaceted regulation and functions of PKM2 in tumor progression.
    Li Z; Yang P; Li Z
    Biochim Biophys Acta; 2014 Dec; 1846(2):285-96. PubMed ID: 25064846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Metabolism enzyme controls cancer stemness].
    Konno M; Doki Y; Mori M; Ishii H
    Nihon Rinsho; 2015 May; 73(5):745-50. PubMed ID: 25985625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-metabolic functions of pyruvate kinase M2: PKM2 in tumorigenesis and therapy resistance.
    İlhan M
    Neoplasma; 2022 Jul; 69(4):747-754. PubMed ID: 35471978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyruvate kinase M2 (PKM2) in cancer and cancer therapeutics.
    Zhu S; Guo Y; Zhang X; Liu H; Yin M; Chen X; Peng C
    Cancer Lett; 2021 Apr; 503():240-248. PubMed ID: 33246091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. iNOS-derived nitric oxide promotes glycolysis by inducing pyruvate kinase M2 nuclear translocation in ovarian cancer.
    Li L; Zhu L; Hao B; Gao W; Wang Q; Li K; Wang M; Huang M; Liu Z; Yang Q; Li X; Zhong Z; Huang W; Xiao G; Xu Y; Yao K; Liu Q
    Oncotarget; 2017 May; 8(20):33047-33063. PubMed ID: 28380434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activators of PKM2 in cancer metabolism.
    Warner SL; Carpenter KJ; Bearss DJ
    Future Med Chem; 2014 Jun; 6(10):1167-78. PubMed ID: 25078136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posttranslational Modifications of Pyruvate Kinase M2: Tweaks that Benefit Cancer.
    Prakasam G; Iqbal MA; Bamezai RNK; Mazurek S
    Front Oncol; 2018; 8():22. PubMed ID: 29468140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of PKM2 in directing the metabolic fate of glucose in cancer: a potential therapeutic target.
    van Niekerk G; Engelbrecht AM
    Cell Oncol (Dordr); 2018 Aug; 41(4):343-351. PubMed ID: 29797241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HDAC8-dependent deacetylation of PKM2 directs nuclear localization and glycolysis to promote proliferation in hepatocellular carcinoma.
    Zhang R; Shen M; Wu C; Chen Y; Lu J; Li J; Zhao L; Meng H; Zhou X; Huang G; Zhao X; Liu J
    Cell Death Dis; 2020 Dec; 11(12):1036. PubMed ID: 33279948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.